Skip to main content
Sign In

University of Colorado Cancer Center

University of Colorado Cancer Center, A National Cancer Institute-designated Comprehensive Cancer Center

Paul A. Bunn, Jr, MD and Barb Helfrich, MSc



Cell growth, death and senescence, signaling pathways and experimental and molecular therapeutics


Lung Cancer, Medical Oncology


University of Colorado Anschutz Medical Campus


Must have completed two years of college

Openings: 1

Program Overview:

To learn experimental techniques used in basic cancer research, especially those employing new treatment modalities to interrupt the growth factor pathways of lung cancer.

Program Description:

Students will be involved with a variety of laboratory procedures, including: 1) cell culture of human lung cancer cell lines;  2) assays to assess treatment cytotoxicity: growth curves, clonogenic assays, and MTT assay;  3) treatment of cell lines with novel molecularly targeted agents or shRNA alone and in combination that target growth factor pathways critical to tumor cell survival; and  4) studies to determine the mechanism of action of candidate agents with potential therapeutic utility in lung cancers (Western blots).


© The Regents of the University of Colorado, a body corporate. All rights reserved.

Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.